+499.5%
MRNA vs FIVN
+27.5%
+472.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FIVN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.4% | +0.2% | -1.9% |
| 7D | +5.5% | -2.3% | +7.8% | +5.8% |
| 30D | +158.7% | +12.4% | +146.3% | +154.7% |
| 3M | +182.1% | +36.0% | +146.1% | +172.8% |
| 6M | +151.8% | +86.0% | +65.8% | +136.8% |
| YTD | +393.6% | +65.9% | +327.6% | +366.5% |
| 1Y | +499.5% | +26.5% | +473.0% | +520.4% |
| All | +499.5% | +27.5% | +472.0% | +520.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FIVN.
Daily Out/Under-Performance
Portfolio return minus FIVN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FIVN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FIVN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling